Demonstration Formulary
 
back
4 Central nervous system

PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control

 

04-08-01 Carbamazepine and Oxcarbazepine

Carbamazepine
Formulary

Tablets

M/R tablets

SF liquid

Suppositories

Tegretol is the preferred brand for new patients however please ensure that existing patients are maintained on a specific manufacturers brand

MHRA Advice
Patients being treated for epilepsy should be maintained on a specific manufacturer's product

Link  NICE CG 137: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care
Link  UKMI Q&A: Why is there a limit on the dose and duration of use for carbamazepine suppositories?

All settings View adult BNF  View SPC online  View childrens BNF
Eslicarbazepine
Formulary

Should only be considered following referral to a tertiary care specialists  and after oxcarbazepine has been tried

Supported by an ESCA

Link  ESCA: Eslicarbazepine
Link  NICE CG 137: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care

Shared care agreement View adult BNF  View SPC online  View childrens BNF
Oxcarbazepine
Formulary

Tablets

Oral suspension

On specialist advice

MHRA Advice
Care should be taken when switching between oral formulations. The need for continued supply of a particluar manufacturer's product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history

Link  NICE CG137: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care

Specialist advice View adult BNF  View SPC online  View childrens BNF